ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.77 -0.0233 (-2.94%) Market Cap: 21.02 Mil Enterprise Value: 29.23 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 53/100

Q4 2022 Immunoprecise Antibodies Ltd Earnings Call Transcript

Jul 29, 2022 / 02:30PM GMT
Release Date Price: $4.23 (-7.03%)
Operator

Good morning and thank you for joining us. My name is Chantel, and I will be your conference operator today. Welcome to IPA's fourth quarter and fiscal year-end earnings conference call. Also on the call with me today are Jennifer Bath, Chief Executive Officer; Lisa Helbling, Chief Financial Officer; and Brad McConn, Vice President of Finance.

Before we get started, some statements we make today may be considered forward-looking statements for the purpose of applicable United States and Canadian security laws. IPA cautions that these forward-looking statements are subject to risks and uncertainties and may cause actual results to differ materially from those indicated in these forward-looking statements. Additional information about these risks and uncertainties is included in our SEC filing. IPA undertakes no obligations to update the forward-looking statements, except as required by law.

On today's conference call, non-GAAP financial measures will be used to help investors understand IPA's business performance. We refer current and potential investors to the forward-looking information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot